Aseptic Process Simulation (APS), commonly known as Media Fill, is a critical validation activity used to demonstrate that aseptic manufacturing processes can consistently produce sterile products under routine and worst-case operating conditions.
Micron Pharma Consultants provides comprehensive consulting support for planning, executing, evaluating, and documenting media fill studies in accordance with international regulatory expectations, including USFDA, EU GMP Annex 1, WHO GMP, and PIC/S guidelines.
Our consultants work closely with organizations to establish scientifically justified process simulations, evaluate aseptic interventions, identify contamination risks, and strengthen sterility assurance programs while ensuring inspection readiness.
Media Fill Protocol Development
Risk Assessment for Aseptic Processes
Process Simulation Design
Worst-Case Condition Evaluation
Critical Intervention Assessment
Media Fill Execution Support
Personnel Qualification Support
Environmental Monitoring Review
Media Fill Report Preparation
Failure Investigation & Root Cause Analysis
CAPA & Remediation Support
Regulatory Inspection Readiness
APS Protocols
Risk Assessment Reports
Execution Support Documentation
Final Media Fill Reports
Investigation & CAPA Reports
Regulatory-Compliant Documentation